Department of Hepatobiliary Surgery, PLA Navy General Hospital, No. 6 Fucheng Road, Beijing 100048, China.
Eur J Surg Oncol. 2013 Aug;39(8):858-64. doi: 10.1016/j.ejso.2013.04.003. Epub 2013 May 11.
The preoperative predictors of microvascular invasion (MVI) in multinodular hepatocellular carcinoma (HCC) are currently unclear.
We retrospectively analyzed 266 patients who underwent potentially curative resection of multinodular HCC. MVI was diagnosed on pathological examination in 64 patients. Preoperative risk factors for MVI were identified and survival curves were analyzed.
Patients with MVI had significantly lower overall and recurrence-free survival rates than those without MVI (overall survival, 1 year: 86% vs. 71%, 3 years: 58% vs. 16%; recurrence-free survival, 1 year: 69% vs. 12%; 3 years: 48% vs. 12%; both P < 0.001). Multivariate analysis showed that serum alpha-fetoprotein (AFP) level >400 μg/L (odds ratio [OR] = 3.732, P = 0.016), serum gamma-glutamyltransferase (GGT) level >130 U/L (OR = 19.779, P < 0.001), total tumor diameter >8 cm (OR = 5.545, P = 0.010), and tumor number >3 (OR = 11.566, P = 0.007) were independent predictors of MVI. A scoring system was constructed, and the MVI rate was significantly higher in patients with a score of ≥3 than those with a score of <3 (64.1% vs. 10.9%, P < 0.001). Overall and recurrence-free survival rates were significantly lower in patients with a score of ≥3 (both P < 0.001).
Serum AFP level >400 μg/L, serum GGT level >130 U/L, total tumor diameter >8 cm, and tumor number >3 were preoperative predictors of MVI in patients with multinodular HCC. In patients with a high risk of MVI and well-preserved liver function, anatomic resection may be worth considering.
目前尚不清楚多结节性肝细胞癌(HCC)中微血管侵犯(MVI)的术前预测因素。
我们回顾性分析了 266 例接受多结节性 HCC 根治性切除术的患者。64 例患者的 MVI 经病理检查诊断。确定 MVI 的术前危险因素,并分析生存曲线。
MVI 患者的总生存率和无复发生存率明显低于无 MVI 患者(总生存率:1 年为 86%比 71%,3 年为 58%比 16%;无复发生存率:1 年为 69%比 12%,3 年为 48%比 12%;均 P<0.001)。多变量分析显示,血清甲胎蛋白(AFP)水平>400μg/L(比值比[OR] = 3.732,P = 0.016)、血清γ-谷氨酰转肽酶(GGT)水平>130 U/L(OR = 19.779,P<0.001)、肿瘤总直径>8cm(OR = 5.545,P = 0.010)和肿瘤数目>3 个(OR = 11.566,P = 0.007)是 MVI 的独立预测因素。构建了评分系统,评分≥3 分的患者 MVI 发生率明显高于评分<3 分的患者(64.1%比 10.9%,P<0.001)。评分≥3 分的患者总生存率和无复发生存率明显较低(均 P<0.001)。
血清 AFP 水平>400μg/L、血清 GGT 水平>130 U/L、肿瘤总直径>8cm、肿瘤数目>3 个是多结节性 HCC 患者 MVI 的术前预测因素。对于 MVI 风险高且肝功能良好的患者,解剖性切除术可能值得考虑。